People · Operator

Zvika Slovin

Named in public records as an officer, director or promoter · active 2009–2021 · Other Health Care, Biotechnology

2
Companies
6
Filings
$31.9M
Combined raised · real
Serial
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
NotalVision, Inc.Other Health CareSeries B$16.4M$272.2M2021
Impliant IncBiotechnologySeries A$15.6M$240.5M2009
Operator network

Zvika Slovin at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

John Hall · 11 companies · 1 sharedJohn HallGuy Katsav · 3 companies · 1 sharedGuy KatsavQuinton Oswald · 3 companies · 1 sharedQuinton OswaldAnat Loewenstein · 1 companies · 1 sharedAnat LoewensteinBarak Azmon · 1 companies · 1 sharedBarak AzmonEliot Lazar, MD · 1 companies · 1 sharedEliot Lazar, MDKester Nahen · 1 companies · 1 sharedKester NahenDavid Cohen · 38 companies · 1 sharedDavid CohenCharles Cohen · 6 companies · 1 sharedCharles CohenDalia Megiddo · 3 companies · 1 sharedDalia MegiddoBRIAN CAMERON · 2 companies · 1 sharedBRIAN CAMERONImpliant Ltd. · 1 companies · 1 sharedImpliant Ltd.Limor Sundach · 1 companies · 1 sharedLimor SundachTodd Potokar · 1 companies · 1 sharedTodd PotokarNotalVision, Inc. · $16.4M raisedNotalVision, Inc.Impliant Inc · $15.6M raisedImpliant IncZvika SlovinZS
Zvika Slovin Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Zvika Slovin on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
David Cohen138
John Hall111
Charles Cohen16
Quinton Oswald13
Dalia Megiddo13
Guy Katsav13
BRIAN CAMERON12
Impliant Ltd.11
Kester Nahen11
Anat Loewenstein11
Barak Azmon11
Eliot Lazar, MD11
Limor Sundach11
Todd Potokar11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.